Table 2.
Clinical and histopathological data of HGSC patients.
| Characteristic | Detail | Datum |
|---|---|---|
| Age (y) | Mean ± SD | 61.5 ± 11.4 |
| Ascites (n (%)) | 54 (54.5) | |
| Chemotherapy with reported follow-up (N = 71) a (n (%)) | Responders (at least 6 months DFS) | 53 (74.6) |
| Non-responders (6 months DFS was not achieved) | 18 (25.4) | |
| FIGO stage (N = 99) | I–II | 19 |
| III–IV | 80 | |
| Follow-up (y) | Range | 0.3–11.3 |
| Median | 3.1 | |
| 5-year survival rate a (n (%)) | 29 (29.3) |
a Cases with missing data: 2 with other malignant disease, 6 did not receive chemotherapy, 15 had no follow-up data after chemotherapy, and 5 had no data about treatment. N, number of patients; SD, standard deviation; DFS, disease-free survival.